Daniel Ferraz de Campos Mazo

Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study

Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Luca Miele et al. · Nutrition Metabolism and Cardiovascular Diseases · 2017 · 132 citations · Full text

Obesity, Nutrition, Gut Microbiome Composition +14

Combination of <i>N</i> ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis

Cláudia P. Oliveira, José Tadeu Stefano, Érika Rabelo Forte de Siqueira et al. · Hepatology Research · 2007 · 107 citations

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Validation of the Brazilian version of mini-test CASI-S

Alfredo Damasceno, Adriane Maira Delicio, Daniel Ferraz de Campos Mazo et al. · Arquivos de Neuro-Psiquiatria · 2005 · 66 citations · Full text

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C

Taisa Grotta Ragazzo, Denise Cerqueira Paranaguá‐Vezozzo, Fabiana Roberto Lima et al. · Clinics · 2017 · 64 citations · Full text